bold = Main text
Part, Chapter, Paragraph grey = Comment text
1 Intro | human organs and tissues.(1) Xenotransplantation, the transplantation of
2 Intro | donors. ~However, before xenotransplantation becomes a clinical reality,
3 Intro | there are concerns about xenotransplantation that require theological,
4 I, 1,1(3) | Baboon-to-human cardiac xenotransplantation in a neonate, JAMA, 1985,
5 I, 1,1(5) | Starzl T.E. Baboon liver xenotransplantation. In: Cooper D.K.C., Kemp
6 I, 1,1(6) | after baboon-to-human liver xenotransplantation. J Virol. 2001; 75: 2825-
7 I, 1,1(7) | Cooper D.K.C. Clinical xenotransplantation - A brief review of the
8 I, 1,1 | potential source animals for xenotransplantation.(9) The use of genetic engineering
9 I, 1,1(8) | Cf. Allan J.F. Xenotransplantation at a crossroad: prevention
10 I, 1,1 | Therefore, certain barriers to xenotransplantation remain.(11) ~Further genetic
11 I, 1,1(10) | kidney xenograft model, Xenotransplantation 2000, 7: 186-96; Cozzi E.,
12 I, 1,1(10) | the study of discordant xenotransplantation, Transplantation 2001; 7:
13 I, 1,1(11) | Murase N., et al., Will xenotransplantation ever be feasible?, J Am
14 I, 1,1 | Clearly more research in xenotransplantation is needed and should be
15 I, 2,2 | achieving successful organ xenotransplantation from pig to primate (human
16 I, 2,2(15) | plasmapheresis/immunoadsorption, Xenotransplantation 1995, 2: 253-63. ~
17 I, 2,2(16) | rejection following discordant xenotransplantation in a nonhuman primate model,
18 I, 2,2(16) | vivo model of pig-to-human xenotransplantation, Transplantation 1995, 60:
19 I, 2,2(18) | the study of discordant xenotransplantation, Transplantation 2001; 7:
20 I, 2,2 | immunological barrier to successful xenotransplantation. Studies of acute vascular
21 I, 2,2(21) | Acute vascular rejection, Xenotransplantation 1998, 5: 169-175. ~
22 I, 2,2(23) | Cf. Bach F.H., Xenotransplantation: problems and prospects,
23 I, 2,2(26) | of vascular responses in xenotransplantation: inflammation and apoptosis,
24 I, 2,3 | Experimental Models ~3. Xenotransplantation of organs has been studied
25 I, 2,4(38) | transmission in pig-to-human xenotransplantation, Xenotransplantation 2000;
26 I, 2,4(38) | pig-to-human xenotransplantation, Xenotransplantation 2000; 7: 143-155. ~
27 I, 2,4(39) | production Specification for xenotransplantation, Ann. NY Acad. Sc. 1998,
28 I, 2,5 | favour further development of xenotransplantation relate to producing transgenic
29 I, 2,5 | advance in the development of xenotransplantation. ~
30 I, 3,6(46) | Holgersson J., Widner H., Xenotransplantation for CNS repair: immunological
31 I, 3,6(48) | et al., Report of the xenotransplantation advisory committee of the
32 I, 3,6(48) | transplantation. The present status of xenotransplantation and its potential role in
33 II | and technical aspects of xenotransplantation described in the first part
34 II, 1 | specifically related to xenotransplantation: 1) the acceptability of
35 II, 1,8 | assessment on the practice of xenotransplantation, we do well to consider
36 II, 1,8 | totally new application in xenotransplantation, which, therefore, in principle
37 II, 1,8 | creation. On the contrary, xenotransplantation represents for man a further
38 II, 1,9 | man, as is the case with xenotransplantation of organs or tissues to
39 II, 1,9 | identity is not affected by xenotransplantation, and once all the general
40 II, 1,10 | Xenotransplantation and the Identity of the
41 II, 1,10 | evaluation of the practice of xenotransplantation must be measured against
42 II, 1,10 | Any ethical appraisal of xenotransplantation must ultimately address
43 II, 1,12 | pronouncements of the Magisterium on xenotransplantation, which see this as one of
44 II, 1,12 | the moral legitimacy of xenotransplantation. First Pius XII (Address
45 II, 1,12 | the moral legitimacy of xenotransplantation: health risk. We shall discuss
46 II, 1,12 | transplant apply also for xenotransplantation.(63) ~~
47 II, 2 | of the practicability of xenotransplantation, in light of the current
48 II, 2 | specifically related to xenotransplantation.(64) ~
49 II, 2,12(64)| Medical Progress. The case of Xenotransplantation, Hastings Center Report
50 II, 2,12(64)| Transplants: the Ethics of Xenotransplantation, London: Nuffield Council
51 II, 2,12(64)| Xenograft Transplantation, Xenotransplantation: Science, Ethics, and Public
52 II, 2,12(64)| et al., Uncertainty in Xenotransplantation: Individual Benefit versus
53 II, 2,12(64)| Piggy Went to Market: The Xenotransplantation and Xenozoonose Debate,
54 II, 2,12(64)| issues concerning the use of Xenotransplantation products in humans: guidance
55 II, 2,13 | judging the legitimacy of xenotransplantation is that of the health risk
56 II, 2,13(66)| to different aspects of xenotransplantation: Appel J.Z., Alwayn I.P.,
57 II, 2,13(66)| Alwayn I.P., Cooper D.K., Xenotransplantation: The Challenge to Current
58 II, 2,14 | to the specific case of xenotransplantation. ~First of all, we note
59 II, 2,14 | are issues connected with xenotransplantation, such as the probability
60 II, 2,14 | to one specific aspect of xenotransplantation: the possible transmission
61 II, 2,14 | Since clinical experience of xenotransplantation is quite limited and certainly
62 II, 2,14 | clinical application of xenotransplantation arrives, it will be necessary
63 II, 2,14 | clinical application of xenotransplantation, psychology should also
64 II, 2,14(67)| Cf. Beckmann J.P., Xenotransplantation aus ethischer Sicht. Eine
65 II, 2,14(67)| Starting Clinical Trials of Xenotransplantation. Reflections on the Ethics
66 II, 2,14(68)| public acceptance of eventual xenotransplantation. See, for example, Mohacsi
67 II, 2,14(68)| Quine S. et al., Aversion to Xenotransplantation, Nature, 1995, 378: 434;
68 II, 2,15 | from engineered animals for xenotransplantation raises the need for certain
69 II, 2,16 | the ethical discussion on xenotransplantation, the subject of informed
70 II, 2,16(70)| infectious disease risks in xenotransplantation, Med Health Care Philos
71 II, 2,17 | Health Care Resources ~17. Xenotransplantation certainly represents a form
72 II, 2,17 | be added that as long as xenotransplantation on man remains at an experimental
73 II, 2,17 | here that the research into xenotransplantation which has taken place so
74 II, 2,17(71)| Cf. Kress J.M., Xenotransplantation: ethics and economics, Food
75 II, 2,17(71)| economic and legal aspects of xenotransplantation, Law Hum Genome Rev 2000
76 II, 2,18 | Patentability and Xenotransplantation ~18. Research on xenotransplantation
77 II, 2,18 | Xenotransplantation ~18. Research on xenotransplantation has hitherto in large measure
78 II, 2,18 | genetically engineered for xenotransplantation into man), is ethically
79 II, 2,18 | of patents connected with xenotransplantation, a procedure which should
80 II, 3,19 | development in the area of xenotransplantation as applied to man. ~Regarding
81 II, 3,19 | applied to man. ~Regarding the xenotransplantation of solid organs, it is of
82 II, 3,19 | extending the practice of xenotransplantation, making it an accepted surgical
83 II, 3,20 | questions and issues related to xenotransplantation have implications of a very
84 II, 3,20 | represent alternatives to xenotransplantation, such as seem to be promised
85 II, 3,21 | legislation on matters of xenotransplantation, it is our heartfelt hope
86 II, 3,21 | infective) connected with xenotransplantation. Furthermore it must offer
87 II, 3,21 | on the important theme of xenotransplantation. May it also be seen as
88 II, 3,21(74)| the Swedish Committee on Xenotransplantation, the Spanish Xenotransplantation
89 II, 3,21(74)| Xenotransplantation, the Spanish Xenotransplantation Sub-committee, the Argentine
90 II, 3,21(74)| Argentine National Commission on Xenotransplantation, the U.S. Department of
91 II, 3,21(74)| Human Services Committee on Xenotransplantation, the United Kingdom Xenotransplantation
92 II, 3,21(74)| Xenotransplantation, the United Kingdom Xenotransplantation Interim Regulatory Authority,
93 II, 3,21(74)| Authority, and the Italian Xenotransplantation Commission. In France, the
94 II, 3,21(74)| to prepare guidelines on xenotransplantation. In Canada "Health Canada'
95 II, 3,21(74)| the authority to regulate xenotransplantation as a new technology.
96 II, 3,21 | disciplines connected with xenotransplantation; this work group met many
97 II, 3,21 | Prof. Fritz H. Bach ~(xenotransplantation, immunogenetics) ~Harvard
98 II, 3,21 | Prof. Fulvio Calise ~(xenotransplantation, clinical experimentation) ~
99 II, 3,21 | the National Commission on Xenotransplantation ~Buenos Aires, ARGENTINA ~-
100 II, 3,21 | Prof. Emanuele Cozzi ~(xenotransplantation, preclinical experimentation) ~
101 II, 3,21 | Marialuisa Lavitrano ~(xenotransplantation, biotechnologies, molecular
102 II, 3,21 | Member of Working Group on Xenotransplantation Council of Europe ~Department
103 II, 3,21 | Prof. Eraldo Seren ~(xenotransplantation, veterinary experimentation) ~
104 II, 3,21 | Prof. Jonathan P. Stoye ~(xenotransplantation, virology-microbiology) ~
|